Human papillomavirus causes anal condylomata, high-grade anal intraepithelial neoplasia, and anal squamous cell cancer. We found high-grade intraepithelial neoplasia or squamous cell cancer in 75 (47%) of 159 HIV-seropositive men who have sex with men (MSM) and in 42 (26%) of 160 HIVseronegative MSM with anal condylomata meriting surgery ( , determined by use of the x 2 test). Anal condylomata P ! .001 in MSM often harbor high-grade intraepithelial neoplasia and squamous cell cancer.
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The 2 main groups of human papillomavirus (HPV) types that infect the anogenital tract are low-risk HPV types, which are associated with the development of anogenital condylomata, and high-risk HPV types, which are implicated in the evolution of anal squamous cell cancer and its putative precursor, highgrade anal intraepithelial neoplasia [1] . Repeated exposure, infection, and shedding of genital HPV are common and overlapping events in sexually active populations, and simultaneous detection of multiple HPV types in the genital tract is a recognized phenomenon, especially in immunosuppressed pop-ulations [2] . HIV-related immunosuppression may increase the chances of both low-grade and high-grade HPV lesions coexisting in the same patient [3] .
The rate of anal squamous cell cancer in HIV-seropositive men who have sex with men (MSM) has increased in the decades following the institution of highly active antiretroviral therapy, suggesting that longer life expectancies may permit established high-risk HPV infections to progress to anal squamous cell cancer in a small proportion of patients [4] . Reports of histopathological findings in anogenital condylomata in large MSM populations are limited. In a study by McCloskey et al [5] , at least one-third of 74 MSM and over half of 26 HIVseropositive MSM had high-grade anal intraepithelial neoplasia within surgically excised warts. We report the prevalence of occult high-grade anal intraepithelial neoplasia and anal squamous cell cancer in a large urban cohort of MSM with anal condylomata too extensive to be amenable to outpatient ablation.
Methods. A retrospective cohort of all MSM referred to a single university-affiliated surgical practice for ablation of anal condylomata from May 2002 through April 2007 was evaluated. Patients were referred from their primary provider or from the affiliated high-resolution anoscopy clinic for evaluation of anogenital warts deemed too widely distributed and/or too large to undergo office treatment. High-resolution anoscopy was used in the operating room to identify all lesions, which were then surgically excised using a CO 2 laser. All excised tissue was submitted for histopathological analysis. Histopathologic grade was recorded as anal intraepithelial neoplasia grade 1, anal intraepithelial neoplasia grade 2 or grade 3 (high-grade anal intraepithelial neoplasia), or anal squamous cell cancer.
The protocol for electronic medical record review underwent formal evaluation and waiver by the Beth Israel Deaconess Medical Center Committee on Clinical Investigations. Subjects with a history of anal high-grade anal intraepithelial neoplasia or anal squamous cell cancer were excluded. Subjects with documented HIV infection were recorded as HIV seropositive, and those with either laboratory documentation or absence of HIV infection on the electronic medical record problem list were recorded as HIV seronegative. If available, presenting symptoms and anal cytology results within 6 months prior to surgery were documented. In HIV-positive subjects, the results of CD4 cell count and HIV viral load within 6 months of surgery were recorded.
Anal cytology specimens were collected from the transformation zone of the anal canal by use of moistened Dacron Results. Table 1 summarizes the clinical characteristics of and the histopathologic findings for the 319 subjects included in the analysis. The cohort was fairly evenly divided between HIV-seropositive subjects (
) and HIV-seronegative subn p 159 jects (
). Most subjects were referred from their prin p 160 mary providers, and more HIV-seropositive subjects were referred from the high-resolution anoscopy clinic than were HIVseronegative subjects. The mean age of the entire cohort was 37 years (range, 18-73 years), and the HIV-seropositive group was significantly older than the HIV-seronegative group (P ! , determined by use of an unpaired t test with Welch cor-.001 rection). Except for the greater proportion of HIV-seronegative subjects presenting with pain ( , determined by use of P p .02 the Fisher exact test), presenting symptoms had similar frequencies regardless of HIV serostatus. There was no significant trend toward increasing frequency of symptoms with worsening histologic grade (data not shown).
Of the 319 subjects in the cohort, 202 (63%) had anal intraepithelial neoplasia grade 1 on histopathological exam, 109 (34%) had high-grade anal intraepithelial neoplasia, and 8 (3%) had anal squamous cell cancer. , determined by use of the Fisher P p .353 exact test). The sensitivity for high-grade squamous intraepithelial lesions on anal cytology for presence of high-grade anal intraepithelial neoplasia or anal squamous cell cancer on histopathology was 90% (95% confidence interval [CI], 81%-96%) over the entire cohort, 93% (95% CI, 83%-98%) for HIV-seropositive subjects, and 89% (95% CI, 73%-98%) for HIV-seronegative subjects. However, the specificity for highgrade squamous intraepithelial lesions on anal cytology for high-grade anal intraepithelial neoplasia or anal squamous cell cancer was only 33% (95% CI, 21%-48%) over the entire cohort, 58% (95% CI, 37%-78%) for HIV-seropositive MSM, and 23% (95% CI, 5%-54%) for HIV-seronegative MSM.
CD4 cell counts and/or HIV viral loads within 6 months of surgery were available for 127 (80%) of the 159 HIV-seropositive subjects. Overall, the mean CD4 cell count was 431 ‫ע‬ cells/mm 3 (range, 4-1153 cells/mm 3 ), and 60 (50%) of 121 238 subjects had detectable viral loads (range, 75-523,000 copies/ mL). There was a trend toward correlation between CD4 cell count and the log 10 (HIV viral load) that did not reach statistical significance ( , determined by use of the Pearson cor-P p .08 relation test). There was no significant overall correlation between either CD4 cell count or HIV viral load and histopathologic grade. The mean CD4 cell count ‫ע(‬ standard deviation) of the 7 HIV-positive subjects with anal squamous cell cancer was lower than that of the rest of the group ( cells/ 218 ‫ע‬ 124 mm 3 vs cells/mm 3 ; , determined by use of 441 ‫ע‬ 237 P p .02 an unpaired t test). There was no correlation between HIV viral load and histopathologic grade.
Discussion. Because anogenital condylomata are classically associated with low-risk HPV types [7] , the presence of highgrade anal intraepithelial neoplasia within what clinically appears to be a low-grade condylomatous lesion is unsettling. rates in the range of 16%-71% in HIV-seropositive populations and in the range of 6%-46% in HIV-seronegative populations [8] [9] [10] .
Our study shows the sensitivity and specificity of high-grade squamous intraepithelial lesions on preoperative anal cytology for detection of high-grade anal intraepithelial neoplasia or anal squamous cell cancer, which are similar to the sensitivity and specificity that we previously reported for the detection of highgrade anal intraepithelial neoplasia by high-resolution anoscopy-assisted biopsy in MSM [11] . Thus, we have observed that the predictive value of high-grade squamous intraepithelial lesions on anal cytology for high-grade anal intraepithelial neoplasia is limited but consistent, regardless of whether the HPVrelated disease is subclinical or severe enough to merit surgical attention.
Several factors limit our study. Because our cohort consisted of referrals for severe condylomatous disease, the pathological associations may not reflect what exists in MSM with smaller burdens of anogenital condylomata. In addition, only one-third of the subjects had high-resolution anoscopy as part of their evaluation. If routine use of high-resolution anoscopy was more likely to result in surgical referrals having a higher likelihood of high-grade anal intraepithelial neoplasia, the prevalence of high-grade anal intraepithelial neoplasia in this population would be underestimated. However, it should be emphasized that operative excision and pathological analysis without routine preoperative high-resolution anoscopy in the majority of the cohort still demonstrated a high prevalence of high-grade anal intraepithelial neoplasia. Associations taking into account racial demographics, smoking, or type of highly active antiretroviral therapy were not captured by our study. Although the age difference between the HIV-seropositive and HIV-seronegative groups may have favored a higher proportion of high-grade anal intraepithelial neoplasia in the HIV-seropositive group, the EXPLORE study did not show age to be a significant factor for the carriage of high-risk HPV types in HIV-seronegative MSM [12] . Finally, if a fundamental difference exists in the development of high-grade anal intraepithelial neoplasia depending on the location of the condylomatous lesion, then detection bias could have influenced our results, because the exact origin of the histopathological specimen (ie, internal anal vs perianal) was not available.
The present study demonstrates that, in a large urban population of MSM, condylomata requiring surgical excision frequently harbored occult high-grade anal intraepithelial neoplasia or anal squamous cell cancer. These data emphasize the importance of obtaining tissue for histopathological examination in MSM presenting for treatment of anogenital condylomata. Prevention of recurrences and careful clinical follow-up of anal condylomata harboring high-grade anal intraepithelial neoplasia may be a method of anal cancer prevention in MSM, particularly in those with HIV infection.
